<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Access Maced J Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Open Access Maced J Med Sci</journal-id><journal-title-group><journal-title>Open Access Macedonian Journal of Medical Sciences</journal-title></journal-title-group><issn pub-type="epub">1857-9655</issn><publisher><publisher-name>Institute of Immunobiology and Human Genetics</publisher-name><publisher-loc>Republic of Macedonia</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27275336</article-id><article-id pub-id-type="pmc">4884259</article-id><article-id pub-id-type="publisher-id">OAMJMS-4-83</article-id><article-id pub-id-type="doi">10.3889/oamjms.2016.024</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Science</subject></subj-group></article-categories><title-group><article-title>Effects of Hormone Replacement Therapy on Insulin Resistance in Postmenopausal Diabetic Women</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bitoska</surname><given-names>Iskra</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Krstevska</surname><given-names>Branka</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Milenkovic</surname><given-names>Tatjana</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Subeska-Stratrova</surname><given-names>Slavica</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Petrovski</surname><given-names>Goran</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Mishevska</surname><given-names>Sasha Jovanovska</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Ahmeti</surname><given-names>Irfan</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Todorova</surname><given-names>Biljana</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><italic>University Clinic of Endocrinology, Diabetology and Metabolic Disorders, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia</italic></aff><author-notes><corresp id="cor1"><label>*</label><bold>Correspondence:</bold> Dr. Iskra Bitoska. University Clinic of Endocrinology, Diabetology and Metabolic Disorders, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia. E-mail: <email xlink:href="ibitovska@yahoo.com">ibitovska@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><day>15</day><month>3</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>01</day><month>2</month><year>2016</year></pub-date><volume>4</volume><issue>1</issue><fpage>83</fpage><lpage>88</lpage><history><date date-type="received"><day>08</day><month>1</month><year>2016</year></date><date date-type="rev-recd"><day>24</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>25</day><month>1</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2016 Iskra Bitoska, Branka Krstevska, Tatjana Milenkovic, Slavica Subeska-Stratrova, Goran Petrovski, Sasha Jovanovska Mishevska, Irfan Ahmeti, Biljana Todorova.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><sec id="st1"><title>BACKGROUND:</title><p>Insulin resistance (IR) is closely associated with diabetes mellitus. On the other hand, increased visceral fat in menopause is also associated with IR, which makes postmenopausal diabetic women in a big risk for cardiovascular diseases. There are conflicting reports about the effects on hormone replacement therapy (HRT) on IR.</p></sec><sec id="st2"><title>AIM:</title><p>The aim of the study was to investigate the effects of HRT on IR.</p></sec><sec id="st3"><title>METHODS:</title><p>A total of 40 postmenopausal women with type 2 diabetes were enrolled and followed for 12 months. Half of them were assigned to take HRT, while the other half made the control group. Fasting plasma glucose (FPG) and insulinemia were measured in both groups at baseline and after 12 months. IR was represented by Homeostatic model assessment for IR (HOMA-IR).</p></sec><sec id="st4"><title>RESULTS:</title><p>HRT was associated with significant decrease in HOMA-IR, FPG and insulinemia in the examined group. There was no significant reduction in FPG and no significant increase in insulinemia levels and HOMA-IR values in control group after 12 months.</p></sec><sec id="st5"><title>CONCLUSION:</title><p>HRT was associated with statistically signifficant increase of insulin sensitivity. Larger clinical trials will be necessary to understand whether HRT may improve insulin resistance and glucose homeostasis in women with diabetes, especially when given shortly after entering menopause.</p></sec></abstract><kwd-group><kwd>Hormone replacement therapy</kwd><kwd>Menopause</kwd><kwd>Diabetes mellitus</kwd><kwd>Insulin resistance</kwd><kwd>HOMA - IR</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Postmenopausal estrogen therapy and estrogen plus progesterone hormone replacement therapy (HRT) alleviate symptoms of menopause and attenuate bone loss [<xref rid="ref1" ref-type="bibr">1</xref>]. Moreover, several observational studies suggest that use of estrogen replacement therapy decreases the risk of coronary heart disease [<xref rid="ref2" ref-type="bibr">2</xref>-<xref rid="ref4" ref-type="bibr">4</xref>] and lowers overall mortality rates [<xref rid="ref5" ref-type="bibr">5</xref>, <xref rid="ref6" ref-type="bibr">6</xref>].</p><p>The menopause transition, as well as the early postmenopausal period, is associated with an increase in total and central obesity [<xref rid="ref7" ref-type="bibr">7</xref>-<xref rid="ref9" ref-type="bibr">9</xref>]. Increased visceral fat is associated with insulin resistance [<xref rid="ref10" ref-type="bibr">10</xref>], and this preferential storage of abdominal fat may contribute to cardiovascular disease and diabetes in postmenopausal women. Estrogen and HRT may improve fat distribution in postmenopausal women by preventing the increase in central body fat [<xref rid="ref7" ref-type="bibr">7</xref>, <xref rid="ref11" ref-type="bibr">11</xref>-<xref rid="ref13" ref-type="bibr">13</xref>]. However, the evidence concerning the effects of HRT on glucose homeostasis is controversial. Estrogen replacement therapy has been reported to have no effect on insulin sensitivity in postmenopausal women [<xref rid="ref14" ref-type="bibr">14</xref>-<xref rid="ref16" ref-type="bibr">16</xref>] and to improve carbohydrate metabolism in individuals with type 2 diabetes [<xref rid="ref18" ref-type="bibr">18</xref>, <xref rid="ref19" ref-type="bibr">19</xref>]. In contrast, nondiabetic women taking estrogen alone were more insulin-resistant than women not on HRT or women taking estrogen and HRT [<xref rid="ref19" ref-type="bibr">19</xref>]. Differences in the study population, type and route of administration of hormone therapy, and method of measuring insulin sensitivity may explain the disparate results of estrogen replacement on glucose metabolism.</p><p>Individuals with insulin resistance require increasing levels of insulin to maintain normal glucose levels and are likely to progress to type 2 diabetes mellitus [<xref rid="ref20" ref-type="bibr">20</xref>]. Insulin resistance is often measured by using the homeostasis model assessment&#x02013;insulin resistance (HOMA-IR) equation, which is a function of the product of fasting insulin and glucose levels [<xref rid="ref21" ref-type="bibr">21</xref>]. Fasting insulin levels are the major indicator of insulin resistance and are increased by obesity and decreased with higher degree of physical activity [<xref rid="ref22" ref-type="bibr">22</xref>]. Despite the potential advantages of measures of insulin resistance, the prognostic value of such measurements has not been extensively evaluated. Estimation of insulin resistance using either levels of insulin, HOMA-IR, glucose, or the ratio of triglycerides and high-density lipoprotein-cholesterol (TG/HDL-C) could potentially improve on cardiovascular risk stratification [<xref rid="ref23" ref-type="bibr">23</xref>].</p><p>Insulin resistance and hyperinsulinemia are clinically important since the effects of insulin have been shown in the formation of atherosclerotic plaques, [<xref rid="ref24" ref-type="bibr">24</xref>] and, hence, increased risk of hypertension and atherosclerosis has been attributed to insulin resistance in postmenopausal women. In these women, fasting glucose and insulin levels decrease with HRT [<xref rid="ref25" ref-type="bibr">25</xref>]. It has been postulated that insulin resistance could decrease with HRT use [<xref rid="ref26" ref-type="bibr">26</xref>]. Different studies resulted in different conclusions; estrogen and progesteron were shown to decrease insulin sensitivity in one study [<xref rid="ref27" ref-type="bibr">27</xref>], but were reported not to affect insulin sensitivity in others [<xref rid="ref27" ref-type="bibr">27</xref>, <xref rid="ref28" ref-type="bibr">28</xref>].</p><p>For this reason, we aimed to study the effects of HRT on IR by the HOMA - IR</p></sec><sec sec-type="methods" id="sec1-2"><title>Patients and Methods</title><p>We prospectively studied 40 women in natural menopause with type 2 diabetes. Diabetes was diagnosed using the criteria of the World Health Organization, at least 2 years before entering the study. In order to maintain their glucose levels in an acceptable range, women with type 2 diabetes were on dietary management alone (two patients) or taking oral anti-diabetic drugs that consisted of metformin and sulfonylureas (38 patients). Each diabetic patient received a diabetic diet of 1300 ckal/day. The women were instructed not to change their diet. None of them were taking insulin. None of the women were taking anti-lipidaemic, corticosteroid or anti-convulsant therapy. The anti-diabetic medications were left unchanged during the study.</p><p>Menopause was confirmed by the absence of menstruation for at least 12 months and by high serum levels of FSH (&#x0003e; 30 mIU/ml) and low serum levels of estradiol (E<sub>2</sub>) (&#x0003c; 20 pg/ml). The subjects had not received HRT previously. Gynaecological examination and mammogram were normal in all subjects.</p><p>Half of the subjects (20 women) were assigned to take HRT (DM &#x02013; HRT) group. The other half (20 women) made the control group, not taking HRT (DM &#x02013; non HRT group). The randomisation of the subjects has been done upon base of willingness and motivation to cooperate. Subjects in the DM - HRT group had been taking oral HRT consisting of 17&#x003b2; - estradiol (E2) 1 mg and DRSP (drospirenone) 2 mg - Angeliq&#x000ae;, Schering AG, Germany, 1 tablet daily for 12 months. Subjects in DM &#x02013; non HRT group were followed the same way as examined group. Exclusion criteria in both groups included <italic>1</italic>) hypertension (systolic blood pressure &#x02265; 140 or diastolic blood pressure &#x02265; 90 mmHg); <italic>2</italic>) anemia; 3) various degrees of renal insufficiency; 4) evidence of significant liver disease; and 5) hysterectomy or a history of recent surgery and who demonstrated significant chronic alcohol intake, were also excluded. All patients in this study gave written informed consent.</p><p>This work was approved by the local medical ethics committee and all participants gave informed consent before the onset of study.</p><p>All of the participants enrolled in our study have been contacted by telephone in three months + interval in order to discover any adverse effect of HRT. All metabolic and physical examinations were performed at the onset of the study and then again after 12 months of receiving HRT. Blood samples were taken after a 12 h fast. HbA<sub>1</sub>C was determined on an Cobas c 111 analyzer using commercial kits supplied from Roche Diagnostic Gmbh (Switzerland), and glucose levels were determined in an Beckman Analyzer 2 automated analyser by using commercial kits supplied from Analox Instruments Ltd, London (UK). Insulinemia was determined in an Elecsys 2010 analyzer using commercial kits from Roche Diagnostics Gmbh (Switzerland).</p><sec id="sec2-1"><title>Assessment of IR</title><p>In primary analysis, we evaluated degrees of IR by homeostatic model assessment for IR (HOMA-IR) using the formulas HOMA-IR = glucose &#x000d7; insulin/22.5. A higher HOMA-IR value indicates greater IR.</p></sec><sec id="sec2-2"><title>Statistical analysis</title><p>Statistical analysis was carried out with descriptive statistics, t - test for related samples and t - test for independent samples. The data are expressed as means &#x000b1; SEM. Statistical significance was set at <italic>P</italic> &#x0003c; 0.05. Data were analysed using Statistica, version 10.0 (StatSoft).</p></sec></sec><sec sec-type="results" id="sec1-3"><title>Results</title><p>All of the women who were enrolled into the investigation completed the study. The mean age of the subjects was 49.3 &#x000b1; 0.34 and 48.5 &#x000b1; 3.1 years, and their mean body mass index (BMI) was 27.27 &#x000b1; 3.32 and 28.3 &#x000b1; 2.4 kg/m<sup>2</sup> in the DM-HRT and DM non-HRT groups respectively. High school educated was 58.3 % and 54.2 %. The baseline characteristics of the subjects are given in <xref ref-type="table" rid="T1">Table 1</xref>. Two subjects in the DM-HRT group and one subject in the DM non-HRT group complained about abnormal vaginal bleeding such as metrorrhagia and four patients reported breast tenderness in the DM-HRT group. Other adverse effects were not seen</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Baseline characteristics of postmenopausal women by HRT status</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Women on HRT (<italic>n</italic> = 20)</th><th align="center" rowspan="1" colspan="1">Women not on HRT (<italic>n</italic> = 20)</th><th align="center" rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">49 &#x000b1; 3.34</td><td align="center" rowspan="1" colspan="1">48.5 &#x000b1; 3.1</td><td align="center" rowspan="1" colspan="1">N/S</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">27 &#x000b1; 3.32</td><td align="center" rowspan="1" colspan="1">28.3 &#x000b1; 2.4</td><td align="center" rowspan="1" colspan="1">N/S</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting plasma glucose (mmol/l)</td><td align="center" rowspan="1" colspan="1">7.8 &#x000b1; 0.86</td><td align="center" rowspan="1" colspan="1">8.0 &#x000b1; 0.9</td><td align="center" rowspan="1" colspan="1">N/S</td></tr><tr><td align="left" rowspan="1" colspan="1">HbA1C (%)</td><td align="center" rowspan="1" colspan="1">7.6 &#x000b1; 0.54</td><td align="center" rowspan="1" colspan="1">7.9 &#x000b1; 0.5</td><td align="center" rowspan="1" colspan="1">N/S</td></tr><tr><td align="left" rowspan="1" colspan="1">Insulinemia(&#x000b5;U/ml)</td><td align="center" rowspan="1" colspan="1">12.2 &#x000b1; 3.41</td><td align="center" rowspan="1" colspan="1">12.3 &#x000b1; 3.2</td><td align="center" rowspan="1" colspan="1">N/S</td></tr><tr><td align="left" rowspan="1" colspan="1">HOMA &#x02013; IR (&#x000b5;U/ml-mmol/l)</td><td align="center" rowspan="1" colspan="1">4.23 &#x000b1; 1.7</td><td align="center" rowspan="1" colspan="1">4.31 &#x000b1; 1.8</td><td align="center" rowspan="1" colspan="1">N/S</td></tr></tbody></table><table-wrap-foot><fn><p>N/S for P value &#x02013; not statistically significant</p></fn></table-wrap-foot></table-wrap><p>There was no statistically significance between two groups at baseline. HRT was associated with statistically significant decreases in serum fasting glucose, HbA1C, insulinemia levels and HOMA &#x02013; IR values in the DM - HRT group. There was no significant reduction in glucose levels and HbA1C together with no significant increase in insulinemia levels and HOMA-IR values in the DM non-HRT group throughout 12 months.</p><p>Regarding group comparison after 12 months, there was statistically significance noted in all examined parameters. Namely, there was statistically significant increase of FPG, HbA1C, insulinemia and HOMA - IR between DM &#x02013; HRT group and DM &#x02013; non HRT group after 12 months. The changes in serum fasting glucose, HbA1c levels, fasting insulin levels and HOMA-IR are given in <xref ref-type="table" rid="T2">Table 2</xref>.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Effects on HRT on Fasting Plasma Glucose (FPG), HbA1C, Insulinemia &#x00026; HOMA &#x02013; IR</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Women on HRT (<italic>n</italic> = 20)</th><th align="center" rowspan="1" colspan="1">P value</th><th align="center" rowspan="1" colspan="1">Women not on HRT (<italic>n</italic> = 20)</th><th align="center" rowspan="1" colspan="1">P value</th><th align="center" rowspan="1" colspan="1">P<xref ref-type="table-fn" rid="t2f1">*</xref> value</th></tr></thead><tbody><tr><td align="left" colspan="5" rowspan="1">FPG (mmol/l)</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">7.8 &#x000b1; 0.86</td><td align="center" rowspan="2" colspan="1">p&#x0003c; 0.001</td><td align="center" rowspan="1" colspan="1">7.8 &#x000b1; 1.1</td><td align="center" rowspan="2" colspan="1">P=0.66</td><td align="center" rowspan="2" colspan="1">P<xref ref-type="table-fn" rid="t2f1">*</xref>&#x0003c; 0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">12 months</td><td align="center" rowspan="1" colspan="1">6.9 &#x000b1; 0.6</td><td align="center" rowspan="1" colspan="1">8.0 &#x000b1; 0.9</td></tr><tr><td align="left" colspan="5" rowspan="1">HbA1C %</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">7.6 &#x000b1; 0.54</td><td align="center" rowspan="2" colspan="1">p&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">7.9 &#x000b1; 0.5</td><td align="center" rowspan="2" valign="bottom" colspan="1">p=0.477</td><td align="center" rowspan="2" valign="bottom" colspan="1">P<xref ref-type="table-fn" rid="t2f1">*</xref>&#x0003c; 0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">12 months</td><td align="center" rowspan="1" colspan="1">7.2&#x000b1; 0.43</td><td align="center" rowspan="1" colspan="1">7,7 &#x000b1; 0.4</td></tr><tr><td align="left" colspan="6" rowspan="1">Insulinemia <break/>(&#x000b5;U/ml)</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">12.2 &#x000b1; 3.41</td><td align="center" rowspan="2" colspan="1">p&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">12.3 &#x000b1; 3.2</td><td align="center" rowspan="2" colspan="1">p= 0.08</td><td align="center" rowspan="2" colspan="1">P<xref ref-type="table-fn" rid="t2f1">*</xref>&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">12 months</td><td align="center" rowspan="1" colspan="1">10.4 &#x000b1; 2.92</td><td align="center" rowspan="1" colspan="1">13.1 &#x000b1; 3.7</td></tr><tr><td align="left" colspan="6" rowspan="1">HOMA &#x02013; IR <break/>(&#x000b5;U/ml-mmol/l)</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">4.23 &#x000b1; 1.7</td><td align="center" rowspan="2" colspan="1">P&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">4.31 &#x000b1; 1.8</td><td align="center" rowspan="2" colspan="1">P=0.69</td><td align="center" rowspan="2" colspan="1">P<xref ref-type="table-fn" rid="t2f1">*</xref>&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">12 months</td><td align="center" rowspan="1" colspan="1">3.18 &#x000b1; 1.4</td><td align="center" rowspan="1" colspan="1">4.54 &#x000b1; 1.7</td></tr></tbody></table><table-wrap-foot><fn><p>P &#x0003c; 0.05 statistically significant for all postmenopausal women included in adequate group at baseline and after 12 months;</p></fn><fn id="t2f1"><label>*</label><p>P &#x0003c; 0.05 statistically significant for group comparison at 12 months.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>The results of the current study indicate that use of HRT in postmenopausal women contributes to the variability in insulin sensitivity observed in diabetic postmenopausal women. Specifically, women taking oral estrogen plus progesterone have higher glucose utilization and insulin sensitivity than women who were not on HRT. Similar to our findings, several studies suggest that estrogen replacement therapy improves glucose homeostasis [<xref rid="ref29" ref-type="bibr">29</xref>-<xref rid="ref31" ref-type="bibr">31</xref>]. HRT - treated women had significantly lower fasting insulin levels than women not taking HRT [<xref rid="ref32" ref-type="bibr">32</xref>]. Glucose utilization by the hyperinsulinemiceuglycemic clamp had a tendency to increase, and HbA1c significantly decreased after 3 months of oral estradiol therapy in postmenopausal women with type 2 diabetes and moderate hyperandrogenicity [<xref rid="ref33" ref-type="bibr">33</xref>]. The dose of therapy may be important such that low doses of conjugated equine estrogen improved insulin sensitivity by ITT, but higher doses resulted in deterioration of insulin sensitivity [<xref rid="ref34" ref-type="bibr">34</xref>].</p><p>Other studies report that estrogen therapy does not affect carbohydrate metabolism [<xref rid="ref14" ref-type="bibr">14</xref>-<xref rid="ref16" ref-type="bibr">16</xref>, <xref rid="ref35" ref-type="bibr">35</xref>-<xref rid="ref37" ref-type="bibr">37</xref>]. In the Postmenopausal Estrogen/Progestin Interventions Trial [<xref rid="ref14" ref-type="bibr">14</xref>], women were given estrogen alone or one of three estrogen/progestin regimens for 3 years. Fasting insulin levels decreased nonsignificantly in women on active treatments, and changes in 2-h insulin did not differ between treatments or with the treatments. Furthermore, estrogen replacement therapy did not change HbA1c and insulin area under the OGTT curve in patients with diabetes [<xref rid="ref35" ref-type="bibr">35</xref>, <xref rid="ref36" ref-type="bibr">36</xref>] or change glucose tolerance or glucose uptake by the hyperinsulinemiceuglycemic clamp in healthy postmenopausal women [<xref rid="ref15" ref-type="bibr">15</xref>, <xref rid="ref16" ref-type="bibr">16</xref>]. Additional reports conclude that estrogen therapy may, in fact, worsen glucose homeostasis [<xref rid="ref32" ref-type="bibr">32</xref>&#x02013;<xref rid="ref35" ref-type="bibr">35</xref>]. Randomized trials of postmenopausal women indicate that 6&#x02013;18 months of HRT increase fasting insulin levels [<xref rid="ref33" ref-type="bibr">33</xref>] and decrease insulin sensitivity using either the intravenous glucose tolerance test (IVGTT) [<xref rid="ref34" ref-type="bibr">34</xref>] or the insulin tolerance test (ITT) [<xref rid="ref35" ref-type="bibr">35</xref>].</p><p>Differences in the study population (healthy versus diabetic postmenopausal women), type of therapy (estradiol versus the combination of estradiol plus progestin), and method of measuring insulin sensitivity (fasting insulin concentrations, OGTT, ITT, IVGTT, glucose clamp) may explain the disparate results of HRT on glucose metabolism. Moreover, the route of estrogen administration may contribute to discrepancies in findings such that transdermal therapy may [<xref rid="ref15" ref-type="bibr">15</xref>] or may not affect glucose metabolism [<xref rid="ref36" ref-type="bibr">36</xref>, <xref rid="ref37" ref-type="bibr">37</xref>]. However, because none of the women in our study were using transdermal estradiol therapy, this does not contribute to the differences in glucose utilization observed.</p><p>The mechanism by which estrogen treatment may alter insulin action in humans is not completely understood. Similar to our results, animal studies would suggest that estradiol maintains or improves insulin sensitivity. Estrogen has been shown to increase glucose transport and glucose utilization in muscle cells of animals [<xref rid="ref38" ref-type="bibr">38</xref>, <xref rid="ref39" ref-type="bibr">39</xref>]. Estrogen regulates insulin-induced glucose transport [<xref rid="ref40" ref-type="bibr">40</xref>] through glucose transporter translocation in rat skeletal muscle [<xref rid="ref41" ref-type="bibr">41</xref>]. Moreover, in oophorectomized rats, there is a reduction in insulin-stimulated translocation of GLUT4 to the plasma membrane as well as a reduction in glycogen synthase protein expression in skeletal muscle, which contributes to a decrease in whole-body insulin sensitivity [<xref rid="ref41" ref-type="bibr">41</xref>]. We are unaware of any studies examining skeletal muscle glucose transport in postmenopausal women on or not on HRT. Based on the literature, which suggests that GLUT4 levels do not vary between normal lean glucose-tolerant and obese diabetic subjects [<xref rid="ref42" ref-type="bibr">42</xref>], we would not expect differences in skeletal muscle GLUT4 protein between women taking estrogen, on HRT, or not on HRT. However, it is possible that glycogen synthase, GLUT4 translocation, and/or other early steps in the insulin-signaling pathway change are altered with the use of estrogen or estrogen plus progesterone in women. In addition, another potential mechanism of estrogen on insulin sensitivity could be mediated through estrogen&#x02019;s effect on peripheral vascular reactivity [<xref rid="ref43" ref-type="bibr">43</xref>, <xref rid="ref44" ref-type="bibr">44</xref>].</p><p>In conclusion, our results show that women taking oral HRT are more insulin sensitive than non-hormone users. Additional studies with longer duration and more subjects are needed to determine the cellular mechanisms that could account for the differences in insulin sensitivity between postmenopausal women who are taking estrogen, on combined hormonal therapy, or not on HRT.</p></sec></body><back><fn-group><fn fn-type="other"><p><bold>Competing Interests:</bold> The authors have declared that no competing interests exist.</p></fn></fn-group><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>JC</given-names></name></person-group><article-title>The metabolic and cardiovascular consequences of HRT</article-title><source>Br J Clin Pract</source><year>1995</year><volume>49</volume><fpage>87</fpage><lpage>90</lpage><comment>PMid:7779651</comment><pub-id pub-id-type="pmid">7779651</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>JM</given-names></name><name><surname>Vander</surname><given-names>ZR</given-names></name><name><surname>Hughes</surname><given-names>JP</given-names></name><name><surname>Maddock</surname><given-names>V</given-names></name><name><surname>Kroetz</surname><given-names>FW</given-names></name><name><surname>Ramanathan</surname><given-names>KB</given-names></name><name><surname>Mirvis</surname><given-names>DM</given-names></name></person-group><article-title>Estrogen replacement and coronary artery disease:effect on survival in postmenopausal women</article-title><source>Arch Intern Med</source><year>1990</year><volume>150</volume><fpage>2557</fpage><lpage>2562</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1001/archinte.1990.00390230101014">http://dx.doi.org/10.1001/archinte.1990.00390230101014</uri></comment><comment>PMid:2244772</comment><pub-id pub-id-type="pmid">2244772</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newton</surname><given-names>KM</given-names></name><name><surname>LaCroix</surname><given-names>AZ</given-names></name><name><surname>McKnight</surname><given-names>B</given-names></name><name><surname>Knopp</surname><given-names>RH</given-names></name><name><surname>Siscovick</surname><given-names>DS</given-names></name><name><surname>Heckbert</surname><given-names>SR</given-names></name><name><surname>Weiss</surname><given-names>NS</given-names></name></person-group><article-title>Estrogen replacement therapy and prognosis after first myocardial infarction</article-title><source>Am J Epidemiol</source><year>1997</year><volume>145</volume><fpage>269</fpage><lpage>277</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1093/oxfordjournals.aje.a009100">http://dx.doi.org/10.1093/oxfordjournals.aje.a009100</uri></comment><comment>PMid:9012600</comment><pub-id pub-id-type="pmid">9012600</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Keefe</surname><given-names>JH</given-names><suffix>Jr</suffix></name><name><surname>Kim</surname><given-names>SC</given-names></name><name><surname>Hall</surname><given-names>RR</given-names></name><name><surname>Cochran</surname><given-names>VC</given-names></name><name><surname>Lawhorn</surname><given-names>SL</given-names></name><name><surname>McCallister</surname><given-names>BD</given-names></name></person-group><article-title>Estrogen replacement therapy after coronary angioplasty in women</article-title><source>J Am Coll Cardiol</source><year>1997</year><volume>29</volume><fpage>1</fpage><lpage>5</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1016/S0735-1097(96)00443-3">http://dx.doi.org/10.1016/S0735-1097(96)00443-3</uri></comment><pub-id pub-id-type="pmid">8996287</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cauley</surname><given-names>JA</given-names></name><name><surname>Seeley</surname><given-names>DG</given-names></name><name><surname>Browner</surname><given-names>WS</given-names></name><name><surname>Ensrud</surname><given-names>K</given-names></name><name><surname>Kuller</surname><given-names>LH</given-names></name><name><surname>Lipschutz</surname><given-names>RC</given-names></name><name><surname>Hulley</surname><given-names>SB</given-names></name></person-group><article-title>Estrogen replacement therapy and mortality among older women:the study of osteoporotic fractures</article-title><source>Arch Intern Med</source><year>1997</year><volume>157</volume><fpage>2181</fpage><lpage>2187</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1001/archinte.1997.00440400031004">http://dx.doi.org/10.1001/archinte.1997.00440400031004</uri></comment><comment>PMid:9342994</comment><pub-id pub-id-type="pmid">9342994</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname><given-names>BE</given-names></name><name><surname>Paganini-Hill</surname><given-names>A</given-names></name><name><surname>Ross</surname><given-names>RK</given-names></name></person-group><article-title>Decreased mortality in users of estrogen replacement therapy</article-title><source>Arch. Intern. Med</source><year>1991</year><volume>151</volume><fpage>75</fpage><lpage>78</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1001/archinte.1991.00400010095012">http://dx.doi.org/10.1001/archinte.1991.00400010095012</uri></comment><comment>PMid:1985611</comment><pub-id pub-id-type="pmid">1985611</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gambacciani</surname><given-names>M</given-names></name><name><surname>Ciaponi</surname><given-names>M</given-names></name><name><surname>Cappagli</surname><given-names>B</given-names></name><name><surname>Piaggesi</surname><given-names>L</given-names></name><name><surname>De Simone</surname><given-names>L</given-names></name><name><surname>Orlandi</surname><given-names>R</given-names></name><name><surname>Genazzani</surname><given-names>AR</given-names></name></person-group><article-title>Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women</article-title><source>J Clin Endocrinol Metab</source><year>1997</year><volume>82</volume><fpage>414</fpage><lpage>417</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1210/jcem.82.2.3735">http://dx.doi.org/10.1210/jcem.82.2.3735</uri></comment><comment>PMid:9024228</comment><pub-id pub-id-type="pmid">9024228</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poehlman</surname><given-names>ET</given-names></name><name><surname>Toth</surname><given-names>MJ</given-names></name><name><surname>Gardner</surname><given-names>AW</given-names></name></person-group><article-title>Changes in energy balance and body composition at menopause:a controlled longitudinal study</article-title><source>Ann Intern Med</source><year>1995</year><volume>123</volume><fpage>673</fpage><lpage>675</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.7326/0003-4819-123-9-199511010-00005">http://dx.doi.org/10.7326/0003-4819-123-9-199511010-00005</uri></comment><comment>PMid:7574222</comment><pub-id pub-id-type="pmid">7574222</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crook</surname><given-names>D</given-names></name><name><surname>Godsland</surname><given-names>IF</given-names></name><name><surname>Hull</surname><given-names>J</given-names></name><name><surname>Stevenson</surname><given-names>JC</given-names></name></person-group><article-title>Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol:effects on serum lipoproteins and glucose tolerance during 24 month follow up</article-title><source>Br J Obstet Gynaecol</source><year>1997</year><volume>104</volume><fpage>298</fpage><lpage>304</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1111/j.1471-0528.1997atb11457.x">http://dx.doi.org/10.1111/j.1471-0528.1997atb11457.x</uri></comment><comment>PMid:9091005</comment><pub-id pub-id-type="pmid">9091005</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cefalu</surname><given-names>WT</given-names></name><name><surname>Wang</surname><given-names>ZQ</given-names></name><name><surname>Werbel</surname><given-names>S</given-names></name><name><surname>Bell-Farrow</surname><given-names>A</given-names></name><name><surname>Crouse</surname><given-names>JR</given-names><suffix>III</suffix></name><name><surname>Hinson</surname><given-names>WH</given-names></name><name><surname>Terry</surname><given-names>JG</given-names></name><name><surname>Anderson</surname><given-names>R</given-names></name></person-group><article-title>Contribution of visceral fat mass to the insulin resistance of aging</article-title><source>Metabolism</source><year>1995</year><volume>44</volume><fpage>954</fpage><lpage>959</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1016/0026-0495(95)90251-1">http://dx.doi.org/10.1016/0026-0495(95)90251-1</uri></comment><pub-id pub-id-type="pmid">7616857</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanggi</surname><given-names>W</given-names></name><name><surname>Lippuner</surname><given-names>K</given-names></name><name><surname>Jaeger</surname><given-names>P</given-names></name><name><surname>Birkhauser</surname><given-names>MH</given-names></name><name><surname>Horber</surname><given-names>FF</given-names></name></person-group><article-title>Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women</article-title><source>Clin Endocrinol (Oxf)</source><year>1998</year><volume>48</volume><issue>6</issue><fpage>691</fpage><lpage>699</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1046/j.1365-2265.1998.00481ax">http://dx.doi.org/10.1046/j.1365-2265.1998.00481ax</uri></comment><pub-id pub-id-type="pmid">9713556</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haarbo</surname><given-names>J</given-names></name><name><surname>Marslew</surname><given-names>U</given-names></name><name><surname>Gotfredsen</surname><given-names>A</given-names></name><name><surname>Christiansen</surname><given-names>C</given-names></name></person-group><article-title>Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause</article-title><source>Metabolism</source><year>1991</year><volume>40</volume><fpage>1323</fpage><lpage>1326</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1016/0026-0495(91)90037-W">http://dx.doi.org/10.1016/0026-0495(91)90037-W</uri></comment><pub-id pub-id-type="pmid">1961129</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samaras</surname><given-names>K</given-names></name><name><surname>Kelly</surname><given-names>PJ</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Chiano</surname><given-names>MN</given-names></name><name><surname>Campbell</surname><given-names>LV</given-names></name></person-group><article-title>Tobacco smoking and oestrogen replacement are associated with lower total and central fat in monozygotic twins</article-title><source>Int J Obes Relat Metab Disord</source><year>1998</year><volume>22</volume><fpage>149</fpage><lpage>156</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1038/sj.ijo.0800558">http://dx.doi.org/10.1038/sj.ijo.0800558</uri></comment><comment>PMid:9504323</comment><pub-id pub-id-type="pmid">9504323</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><collab>Writing Group for the PEPI Trial</collab><article-title>Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women:the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial</article-title><source>JAMA</source><year>1995</year><volume>273</volume><fpage>199</fpage><lpage>208</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1001/jama.1995.03520270033028">http://dx.doi.org/10.1001/jama.1995.03520270033028</uri></comment><pub-id pub-id-type="pmid">7807658</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cagnacci</surname><given-names>A</given-names></name><name><surname>Soldani</surname><given-names>R</given-names></name><name><surname>Carriero</surname><given-names>PL</given-names></name><name><surname>Paoletti</surname><given-names>AM</given-names></name><name><surname>Fioretti</surname><given-names>P</given-names></name><name><surname>Melis</surname><given-names>GB</given-names></name></person-group><article-title>Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women</article-title><source>J Clin Endocrinol Metab</source><year>1992</year><volume>74</volume><fpage>1396</fpage><lpage>1400</lpage><comment>PMid:1317387</comment><pub-id pub-id-type="pmid">1317387</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Sullivan</surname><given-names>AJ</given-names></name><name><surname>Ho</surname><given-names>KK</given-names></name></person-group><article-title>A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women</article-title><source>J Clin Endocrinol Metab</source><year>1995</year><volume>80</volume><fpage>1783</fpage><lpage>1788</lpage><comment>PMid:7775623</comment><pub-id pub-id-type="pmid">7775623</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chmouliovsky</surname><given-names>L</given-names></name><name><surname>Habicht</surname><given-names>F</given-names></name><name><surname>James</surname><given-names>RW</given-names></name><name><surname>Lehmann</surname><given-names>T</given-names></name><name><surname>Campana</surname><given-names>A</given-names></name><name><surname>Golay</surname><given-names>A</given-names></name></person-group><article-title>Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women</article-title><source>Maturitas</source><year>1999</year><volume>32</volume><fpage>147</fpage><lpage>153</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1016/S0378-5122(99)00037-7">http://dx.doi.org/10.1016/S0378-5122(99)00037-7</uri></comment><pub-id pub-id-type="pmid">10515671</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brussaard</surname><given-names>HE</given-names></name><name><surname>Gevers Leuven</surname><given-names>JA</given-names></name><name><surname>Frolich</surname><given-names>M</given-names></name><name><surname>Kluft</surname><given-names>C</given-names></name><name><surname>Krans</surname><given-names>HM</given-names></name></person-group><article-title>Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM</article-title><source>Diabetologia</source><year>1997</year><volume>40</volume><fpage>843</fpage><lpage>849</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1007/s001250050758">http://dx.doi.org/10.1007/s001250050758</uri></comment><comment>PMid:9243107</comment><pub-id pub-id-type="pmid">9243107</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>RC</given-names></name><name><surname>Holman</surname><given-names>RR</given-names></name><name><surname>Matthews</surname><given-names>D</given-names></name><name><surname>Hockaday</surname><given-names>TD</given-names></name><name><surname>Peto</surname><given-names>J</given-names></name></person-group><article-title>Insulin deficiency and insulin resistance interaction in diabetes:estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations</article-title><source>Metabolism</source><year>1979</year><volume>28</volume><fpage>1086</fpage><lpage>1096</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1016/0026-0495(79)90146-X">http://dx.doi.org/10.1016/0026-0495(79)90146-X</uri></comment><pub-id pub-id-type="pmid">386029</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>DR</given-names></name><name><surname>Hosker</surname><given-names>JP</given-names></name><name><surname>Rudenski</surname><given-names>AS</given-names></name><name><surname>Naylor</surname><given-names>BA</given-names></name><name><surname>Treacher</surname><given-names>DF</given-names></name><name><surname>Turner</surname><given-names>RC</given-names></name></person-group><article-title>Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man</article-title><source>Diabetologia</source><year>1985</year><volume>28</volume><fpage>412</fpage><lpage>419</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1007/BF00280883">http://dx.doi.org/10.1007/BF00280883</uri></comment><comment>PMid:3899825</comment><pub-id pub-id-type="pmid">3899825</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Tinker</surname><given-names>L</given-names></name><name><surname>Howard</surname><given-names>BV</given-names></name><name><surname>Kuller</surname><given-names>LH</given-names></name><name><surname>Nathan</surname><given-names>L</given-names></name><name><surname>Rifai</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name></person-group><article-title>Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women:the Women&#x02019;s Health Initiative Observational Study</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><fpage>1747</fpage><lpage>1750</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.2337/dc07-0358">http://dx.doi.org/10.2337/dc07-0358</uri></comment><comment>PMid:17468352 PMCid:PMC1952235</comment><pub-id pub-id-type="pmid">17468352</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbasi</surname><given-names>F</given-names></name><name><surname>Reaven</surname><given-names>GM</given-names></name></person-group><article-title>Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects:triglycerides &#x000d7;glucose versus triglyceride/high-density lipoprotein cholesterol</article-title><source>Metabolism</source><year>2011</year><volume>60</volume><fpage>1673</fpage><lpage>1676</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1016/j.metabol.2011.04.006">http://dx.doi.org/10.1016/j.metabol.2011.04.006</uri></comment><comment>PMid:21632070</comment><pub-id pub-id-type="pmid">21632070</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilligan</surname><given-names>DM</given-names></name><name><surname>Quyyumi</surname><given-names>AA</given-names></name><name><surname>Camon</surname><given-names>RO</given-names></name></person-group><article-title>Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women</article-title><source>Circulation</source><year>1994</year><volume>89</volume><fpage>2545</fpage><lpage>2551</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1161/01aCIR.89.6.2545">http://dx.doi.org/10.1161/01aCIR.89.6.2545</uri></comment><comment>PMid:8205663</comment><pub-id pub-id-type="pmid">8205663</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fineberg</surname><given-names>SE</given-names></name></person-group><article-title>Glycaemic Control and Hormone Replacement Therapy</article-title><source>Drugs Aging</source><year>2000</year><volume>17</volume><issue>6</issue><fpage>453</fpage><lpage>461</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.2165/00002512-200017060-00003">http://dx.doi.org/10.2165/00002512-200017060-00003</uri></comment><comment>PMid:11200306</comment><pub-id pub-id-type="pmid">11200306</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindheim</surname><given-names>SR</given-names></name><name><surname>Natelovitz</surname><given-names>M</given-names></name><name><surname>Feldman</surname><given-names>EB</given-names></name><name><surname>Larsen</surname><given-names>S</given-names></name><name><surname>Khan</surname><given-names>FY</given-names></name><name><surname>Lobo</surname><given-names>RA</given-names></name></person-group><article-title>The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women</article-title><source>Obstet. Gynecol</source><year>1994</year><volume>83</volume><issue>2</issue><fpage>167</fpage><lpage>172</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1016/0020-7292(94)90488-x">http://dx.doi.org/10.1016/0020-7292(94)90488-x</uri></comment><pub-id pub-id-type="pmid">8290176</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><article-title>The Eye Disease Care-Control Study Group</article-title><source>Arch. Ophtholmot</source><year>1996</year><volume>114</volume><fpage>545</fpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1001/archopht.1996.01100130537006">http://dx.doi.org/10.1001/archopht.1996.01100130537006</uri></comment></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sites</surname><given-names>CK</given-names></name><name><surname>Brochu</surname><given-names>M</given-names></name><name><surname>Tchernof</surname><given-names>A</given-names></name><name><surname>Poehlman</surname><given-names>ET</given-names></name></person-group><article-title>Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women</article-title><source>Metabolism</source><year>2001</year><volume>50</volume><issue>7</issue><fpage>835</fpage><lpage>840</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1053/meta.2001.24878">http://dx.doi.org/10.1053/meta.2001.24878</uri></comment><comment>PMid:11436191</comment><pub-id pub-id-type="pmid">11436191</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brussaard</surname><given-names>HE</given-names></name><name><surname>Gevers Leuven</surname><given-names>JA</given-names></name><name><surname>Frolich</surname><given-names>M</given-names></name><name><surname>Kluft</surname><given-names>C</given-names></name><name><surname>Krans</surname><given-names>HM</given-names></name></person-group><article-title>Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM</article-title><source>Diabetologia</source><year>1997</year><volume>40</volume><fpage>843</fpage><lpage>849</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1007/s001250050758">http://dx.doi.org/10.1007/s001250050758</uri></comment><comment>PMid:9243107</comment><pub-id pub-id-type="pmid">9243107</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindheim</surname><given-names>SR</given-names></name><name><surname>Presser</surname><given-names>SC</given-names></name><name><surname>Ditkoff</surname><given-names>EC</given-names></name><name><surname>Vijod</surname><given-names>MA</given-names></name><name><surname>Stanczyk</surname><given-names>FZ</given-names></name><name><surname>Lobo</surname><given-names>RA</given-names></name></person-group><article-title>A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin</article-title><source>Fertil Steril</source><year>1993</year><volume>60</volume><fpage>664</fpage><lpage>667</lpage><comment>PMid:8405521</comment><pub-id pub-id-type="pmid">8405521</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrara</surname><given-names>A</given-names></name><name><surname>Barrett-Connor</surname><given-names>E</given-names></name><name><surname>Wingard</surname><given-names>DL</given-names></name><name><surname>Edelstein</surname><given-names>SL</given-names></name></person-group><article-title>Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status:the Rancho Bernardo Study 1984-1987</article-title><source>Diabetes Care</source><year>1995</year><volume>18</volume><fpage>220</fpage><lpage>225</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.2337/diacare.18.2.220">http://dx.doi.org/10.2337/diacare.18.2.220</uri></comment><comment>PMid:7729301</comment><pub-id pub-id-type="pmid">7729301</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>B</given-names></name><name><surname>Mattsson</surname><given-names>LA</given-names></name><name><surname>Hahn</surname><given-names>L</given-names></name><name><surname>Marin</surname><given-names>P</given-names></name><name><surname>Lapidus</surname><given-names>L</given-names></name><name><surname>Holm</surname><given-names>G</given-names></name><name><surname>Bengtsson</surname><given-names>BA</given-names></name><name><surname>Bjorntorp</surname><given-names>P</given-names></name></person-group><article-title>Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus</article-title><source>J Clin Endocrinol Meta</source><year>1997</year><volume>82</volume><fpage>638</fpage><lpage>643</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1210/jc.82.2.638">http://dx.doi.org/10.1210/jc.82.2.638</uri></comment></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>MD</given-names></name><name><surname>Korytkowski</surname><given-names>MT</given-names></name><name><surname>Zmuda</surname><given-names>JM</given-names></name><name><surname>McCole</surname><given-names>SD</given-names></name><name><surname>Moore</surname><given-names>GE</given-names></name><name><surname>Hagberg</surname><given-names>JM</given-names></name></person-group><article-title>Insulin sensitivity in postmenopausal women:independent and combined associations with hormone replacement, cardiovascular fitness, and body composition</article-title><source>Diabetes Care</source><year>2000</year><volume>23</volume><fpage>1731</fpage><lpage>1736</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.2337/diacare.23.12.1731">http://dx.doi.org/10.2337/diacare.23.12.1731</uri></comment><comment>PMid:11128342</comment><pub-id pub-id-type="pmid">11128342</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samaras</surname><given-names>K</given-names></name><name><surname>Hayward</surname><given-names>CS</given-names></name><name><surname>Sullivan</surname><given-names>D</given-names></name><name><surname>Kelly</surname><given-names>RP</given-names></name><name><surname>Campbell</surname><given-names>LV</given-names></name></person-group><article-title>Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes:a prospective study</article-title><source>Diabetes Care</source><year>1999</year><volume>22</volume><fpage>1401</fpage><lpage>1407</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.2337/diacare.22.9.1401">http://dx.doi.org/10.2337/diacare.22.9.1401</uri></comment><comment>PMid:10480500</comment><pub-id pub-id-type="pmid">10480500</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godsland</surname><given-names>IF</given-names></name><name><surname>Gangar</surname><given-names>K</given-names></name><name><surname>Walton</surname><given-names>C</given-names></name><name><surname>Cust</surname><given-names>MP</given-names></name><name><surname>Whitehead</surname><given-names>MI</given-names></name><name><surname>Wynn</surname><given-names>V</given-names></name><name><surname>Stevenson</surname><given-names>JC</given-names></name></person-group><article-title>Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy</article-title><source>Metabolism</source><year>1993</year><volume>42</volume><fpage>846</fpage><lpage>853</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1016/0026-0495(93)90058-V">http://dx.doi.org/10.1016/0026-0495(93)90058-V</uri></comment><pub-id pub-id-type="pmid">8345794</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindheim</surname><given-names>SR</given-names></name><name><surname>Presser</surname><given-names>SC</given-names></name><name><surname>Ditkoff</surname><given-names>EC</given-names></name><name><surname>Vijod</surname><given-names>MA</given-names></name><name><surname>Stanczyk</surname><given-names>FZ</given-names></name><name><surname>Lobo</surname><given-names>RA</given-names></name></person-group><article-title>A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin</article-title><source>Fertil Steril</source><year>1993</year><volume>60</volume><fpage>664</fpage><lpage>667</lpage><comment>PMid:8405521</comment><pub-id pub-id-type="pmid">8405521</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>AC</given-names></name><name><surname>Lyall</surname><given-names>H</given-names></name><name><surname>Roberts</surname><given-names>RN</given-names></name><name><surname>Petrie</surname><given-names>JR</given-names></name><name><surname>Perera</surname><given-names>MJ</given-names></name><name><surname>Monaghan</surname><given-names>S</given-names></name><name><surname>Hart</surname><given-names>DM</given-names></name><name><surname>Connell</surname><given-names>JM</given-names></name><name><surname>Lumsden</surname><given-names>MA</given-names></name></person-group><article-title>The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women</article-title><source>J Clin Endocrinol Metab</source><year>1999</year><volume>84</volume><fpage>2402</fpage><lpage>2407</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1210/jcem.84.7.5836">http://dx.doi.org/10.1210/jcem.84.7.5836</uri></comment><comment>PMid:10404811</comment><pub-id pub-id-type="pmid">10404811</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>B</given-names></name><name><surname>Mattsson</surname><given-names>LA</given-names></name><name><surname>Hahn</surname><given-names>L</given-names></name><name><surname>Marin</surname><given-names>P</given-names></name><name><surname>Lapidus</surname><given-names>L</given-names></name><name><surname>Holm</surname><given-names>G</given-names></name><name><surname>Bengtsson</surname><given-names>BA</given-names></name><name><surname>Bjorntorp</surname><given-names>P</given-names></name></person-group><article-title>Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus</article-title><source>J Clin Endocrinol Metab</source><year>1997</year><volume>82</volume><fpage>638</fpage><lpage>643</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1210/jc.82.2.638">http://dx.doi.org/10.1210/jc.82.2.638</uri></comment><pub-id pub-id-type="pmid">9024268</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puah</surname><given-names>JA</given-names></name><name><surname>Bailey</surname><given-names>CJ</given-names></name></person-group><article-title>Effect of ovarian hormones on glucose metabolism in mouse soleus muscle</article-title><source>Endocrinology</source><year>1985</year><volume>117</volume><fpage>1336</fpage><lpage>1340</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1210/endo-117-4-1336">http://dx.doi.org/10.1210/endo-117-4-1336</uri></comment><comment>PMid:3896756</comment><pub-id pub-id-type="pmid">3896756</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>DA</given-names></name><name><surname>Garner</surname><given-names>CW</given-names></name></person-group><article-title>Estradiol stimulation of glucose transport in rat uterus</article-title><source>Endocrinology</source><year>1987</year><volume>121</volume><fpage>1366</fpage><lpage>1374</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1210/endo-121-4-1366">http://dx.doi.org/10.1210/endo-121-4-1366</uri></comment><comment>PMid:3653031</comment><pub-id pub-id-type="pmid">3653031</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumagai</surname><given-names>S</given-names></name><name><surname>Holmang</surname><given-names>A</given-names></name><name><surname>Bjorntorp</surname><given-names>P</given-names></name></person-group><article-title>The effects of oestrogen and progesterone on insulin sensitivity in female rats</article-title><source>Acta Physiol Scand</source><year>1993</year><volume>149</volume><fpage>91</fpage><lpage>97</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1111/j.1748-1716.1993atb09596.x">http://dx.doi.org/10.1111/j.1748-1716.1993atb09596.x</uri></comment><comment>PMid:8237427</comment><pub-id pub-id-type="pmid">8237427</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rincon</surname><given-names>J</given-names></name><name><surname>Holmang</surname><given-names>A</given-names></name><name><surname>Wahlstrom</surname><given-names>EO</given-names></name><name><surname>Lonnroth</surname><given-names>P</given-names></name><name><surname>Bjorntorp</surname><given-names>P</given-names></name><name><surname>Zierath</surname><given-names>JR</given-names></name><name><surname>Wallberg-Henriksson</surname><given-names>H</given-names></name></person-group><article-title>Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment</article-title><source>Diabetes</source><year>1996</year><volume>45</volume><fpage>615</fpage><lpage>621</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.2337/diab.45.5.615">http://dx.doi.org/10.2337/diab.45.5.615</uri></comment><comment>PMid:8621012</comment><pub-id pub-id-type="pmid">8621012</pub-id></element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Bak</surname><given-names>JF</given-names></name><name><surname>Andersen</surname><given-names>PH</given-names></name><name><surname>Lund</surname><given-names>S</given-names></name><name><surname>Moller</surname><given-names>DE</given-names></name><name><surname>Flier</surname><given-names>JS</given-names></name><name><surname>Kahn</surname><given-names>BB</given-names></name></person-group><article-title>Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM</article-title><source>Diabetes</source><year>1990</year><volume>39</volume><fpage>865</fpage><lpage>870</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.2337/diab.39.7.865">http://dx.doi.org/10.2337/diab.39.7.865</uri></comment><comment>PMid:2354749</comment><pub-id pub-id-type="pmid">2354749</pub-id></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanada</surname><given-names>M</given-names></name><name><surname>Higashi</surname><given-names>Y</given-names></name><name><surname>Nakagawa</surname><given-names>K</given-names></name><name><surname>Sasaki</surname><given-names>S</given-names></name><name><surname>Kodama</surname><given-names>I</given-names></name><name><surname>Sakashita</surname><given-names>T</given-names></name><name><surname>Tsuda</surname><given-names>M</given-names></name><name><surname>Ohama</surname><given-names>K</given-names></name></person-group><article-title>Oral estrogen replacement therapy increases forearm reactive hyperemia accompanied by increases in serum levels of nitric oxide in postmenopausal women</article-title><source>Gynecol Endocrinol</source><year>2001</year><volume>15</volume><fpage>150</fpage><lpage>157</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1080/gye.15.2.150.157">http://dx.doi.org/10.1080/gye.15.2.150.157</uri></comment><comment>PMid:11379012</comment><pub-id pub-id-type="pmid">11379012</pub-id></element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCrohon</surname><given-names>JA</given-names></name><name><surname>Adams</surname><given-names>MR</given-names></name><name><surname>McCredie</surname><given-names>RJ</given-names></name><name><surname>Robinson</surname><given-names>J</given-names></name><name><surname>Pike</surname><given-names>A</given-names></name><name><surname>Abbey</surname><given-names>M</given-names></name><name><surname>Keech</surname><given-names>AC</given-names></name><name><surname>Celermajer</surname><given-names>DS</given-names></name></person-group><article-title>Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women</article-title><source>Clin Endocrinol</source><year>1996</year><volume>45</volume><fpage>435</fpage><lpage>441</lpage><comment><uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1046/j.1365-2265.1996.8070816ax">http://dx.doi.org/10.1046/j.1365-2265.1996.8070816ax</uri></comment></element-citation></ref></ref-list></back></article>